Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

"Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our ...

Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

Using novel genetic and genomic tools, researchers at the Icahn School of Medicine at Mount Sinai have shed light on the role ...

Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

It's flu season, but not all influenza is the same. If you're feeling sick, it helps to know the difference between flu A and flu B symptoms, experts say.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

See expanded profiles of nearly 1,800 schools. Unlock entering class stats including MCAT, GMAT and GRE scores.